FIGURE 8 Nine different substances were declared as PCT medicines in the samples and, in order of occurrence frequency, they were hCG (n = 16), clomiphene (n = 14), tamoxifen (n = 7), exemestane (n = 7), anastrozole (n = 7), cabergoline (n = 6), mesterolone (n = 4), and letrozole (n = 2)
Adler V, Yin Z, Fuchs SY et al (1999) Regulation of JNK signaling by GSTp
DaVitas 2026 adjusted EPS guidance midpoint of $14.30 exceeds the pre-earnings analyst consensus of $12.65 by 13%, driven by the elimination of a $45 million revenue-per-treatment headwind from the April 2025 ransomware attack, higher reimbursement rates, and the first profitable year in its Integrated Kidney Care unit, which manages risk-based contracts covering roughly $5.6 billion in annual patient spending
Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review